Sunburn and Cutaneous Squamous Cell Carcinoma: A Meta-Analysis

Melanoma and Skin Cancer

Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: a multicenter retrospective study

J Am Acad Dermatol

Hirotsu KE, Aasi SZ, Samson KK, Zheng C, Nazaroff JR, Voller LM, Ruiz ES, Ran NA, Granger EE, Koyfman SA, Vidimos AT, Carr DR, Shahwan KT, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Srivastava D, Brodland DG, Zitelli JA, Willenbrink TJ, Wysong A

doi: 10.1016/j.jaad.2025.04.029

Melanoma and Skin Cancer

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

JAMA Dermatol

Ran NA, Granger EE, Brodland DG, Cañueto J, Carr DR, Carter JB, Carucci JA, Hirotsu KE, Koyfman SA, Mangold AR, Girardi FM, Shahwan KT, Srivastava D, Vidimos AT, Willenbrink TJ, Wysong A, Ruiz ES

doi: 10.1001/jamadermatol.2025.0128

Melanoma and Skin Cancer

Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years

J Am Acad Dermatol

Ruiz ES, Muñoz-Couselo E, Montaudié H, Berciano-Guerrero MA, de la Gala MDCÁ, Charles J, Quéreux G, Nardin C, Tur RY, Dalle S, Beylot-Barry M, Ladwa R, McGrath M, Brungs D, Harris D, Shue H, Tazbirkova A, Fourie S, Malan DR, Oliviero J, Wilcoxen LN, Gray WG, Clingan P

doi: 10.1016/j.jaad.2025.09.009

Melanoma and Skin Cancer

Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma

Br J Dermatol

Laimer M, South AP, Mayr E, Kitzmueller S, Banner L, Alexander M, Hosler L, Yang H, Parris M, Arora M, Zimmermann G, Schweighofer-Zwink G, Bauer JW, Nikbakht N

doi: 10.1093/bjd/ljaf205

Melanoma and Skin Cancer

Development of Gene-Expression Panel Predictive of Local Recurrence, Metastasis, and Overall Survival in Intermediate to High-risk Cutaneous Squamous Cell Carcinoma: A Cohort Study

J Am Acad Dermatol

Leibovit-Reiben Z, Stockard A, Nassir S, Yousif M, Li X, Severson KJ, Hughes A, Kechter J, Hwang A, Boudreaux B, Bhullar P, Zhang N, Butterfield RJ, Ma T, Cardona-Machado CD, Pérez-Baena MJ, Costello CM, Nelson SA, DiCaudo DJ, Baum CL, Pittelkow MR, Cañueto J, Mangold AR

doi: 10.1016/j.jaad.2025.10.136

Melanoma and Skin Cancer

Impact of Disease Stage, Treatment Timing, and Demographic Disparities on Survival in Vulvar Squamous Cell Carcinoma: Insights from a SEER-Based Analysis

J Am Acad Dermatol

Shelton E, Patel J, Taylor MA, Kwapnoski Z, Xu YG

doi: 10.1016/j.jaad.2025.10.013

Melanoma and Skin Cancer

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial

Br J Dermatol

Becker JC, Gesierich AH, Leiter U, Zimmer L, Hassel JC, von Wasielewski I, Ziemer M, Fluck M, Meier F, Spillner AN, Schilling B, Eigentler TK, Livingstone E, Ugurel S, Angela Y, Windemuth-Kieselbach C, Gutzmer R

doi: 10.1093/bjd/ljaf303

Melanoma and Skin Cancer

Radiologic Imaging Aids Management of High-risk Cutaneous Squamous Cell Carcinoma: A Retrospective Cohort Study

J Am Acad Dermatol

Wei AH, Cassard L, Fan C, Seck S, Vazquez MR, Bena J, Stultz T, Koyfman SA, Vidimos AT

doi: 10.1016/j.jaad.2025.04.028

Melanoma and Skin Cancer

Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial

Lancet

Rao S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, Morano F, Roy A, Dahan L, Tamberi S, Dhadda AS, Saunders MP, Casanova N, Guimbaud R, Lievre A, Maurel J, Fakih M, Tian C, Harrison J, Jones MM, Cornfeld M, Spano JP, Rochefort P, POD1UM-303/InterAACT-2 study investigators

doi: 10.1016/S0140-6736(25)00631-2

Related content

Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: a multicenter retrospective study

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years

Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma

Development of Gene-Expression Panel Predictive of Local Recurrence, Metastasis, and Overall Survival in Intermediate to High-risk Cutaneous Squamous Cell Carcinoma: A Cohort Study

Impact of Disease Stage, Treatment Timing, and Demographic Disparities on Survival in Vulvar Squamous Cell Carcinoma: Insights from a SEER-Based Analysis

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial

Radiologic Imaging Aids Management of High-risk Cutaneous Squamous Cell Carcinoma: A Retrospective Cohort Study

Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial